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Background: There is no current way to determine the actual blood and body fluid exposure (BBFE) incidence in 
hospitals. We propose a simple, reliable, and widely available method for the accurate estimation of BBFE.         
Methods: Data for BBFE for healthcare workers between 2006 and 2015 at Osaka University Hospital were retro-
spectively extracted from the electronic records. Annual positivity of hepatitis C virus (HCV) antibody in the 
source individuals and overall patient population were calculated over time. We created an estimation formula fo-
cusing on the difference in HCV positivity between the source individuals and overall patient population for the 
actual number of BBFEs. A linear regression model was used to evaluate the temporal change in the reported and 
estimated BBFEs. 
Results: During the study period, 937 BBFEs were reported. HCV positivity between the post-BBFE cohort and 
overall patient population greatly differed; the incidence ratio ranged from 2.1 to 5.7. The linear regression model 
revealed that the reported BBFEs did not significantly change during the study period (the slope, 1.315 [95% con-
fidence interval (C.I.): -0.849 to 3.480, p = 0.199]). The annual incidence ratio of the estimated and reported 
BBFEs significantly reduced over time (the slope, -0.287 [95% C.I.: -0.488 to -0.086, p = 0.011]), indicating that, 
although the reported number of BBFEs seemed unchanged, the estimated incidence decreased. 
Conclusions: We propose a novel and simple approach to estimating the actual incidence of BBFEs in hospitals us-
ing the difference in HCV positivity between the post-BBFE cohort and overall patient population. 
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Blood and body fluid exposure (BBFE) during daily 
hospital routines is inevitable for health-care workers 
(HCWs) [1], despite the development of safety-engi-
neered devices and accumulated knowledge for preven-
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tion [2]. According to the World Health Organization, 
the annual global incidence of percutaneous BBFE in 
HCWs is as high as 3 million [3]. Although the major 
concerns as a consequence of BBFE are hepatitis B vi-
rus (HBV), hepatitis C virus (HCV), and human immu-
nodeficiency virus (HIV) infections [4], more than       
50 blood-borne pathogens can cause infections after 
BBFE [5]. 
Based on the US General Accounting Office, follow-up 
expenses, excluding treatment, for HCWs after BBFE 
are > $500 per incident [6]. In addition to the financial 
issues, occupational exposure results in emotional dis-
tress. Thus, a systematic approach for the prevention of 
BBFE is expected in hospitals. 
Comprehension of the true incidence of BBFE is of 
great importance for infection control practitioners to 
evaluate their activities for the prevention of occupa-
tional exposure and to develop appropriate preventive 
strategies. Although HCWs are generally supposed to 
report a BBFE incidence to infection control services, 
the number of reported BBFE is almost without excep-
tion less than that of true events [7]. Namely, it is al-
most impossible to determine the actual number of 
BBFEs because of under-reporting [5,8-11]. For exam-
ple, more than 80% of syringe injuries were unreported 
in Taiwan before 2000 [12,13]. Understandably, the re-
ported BBFEs may only be the tip of the iceberg, and a 
decrease in the number of reported BBFEs does not ac-
curately reflect a true reduction in the hospital. No gold 
standard to estimate the actual incidence of BBFE ex-
ists, and all previous interventional or observational 
studies concerning BBFEs have been merely based on 
the reported number, which could under-represent the 
actual incidence [14-16]. 
In this study, we propose a novel, simple, and widely 
available estimation formula that uses HCV positivity in 
a post-BBFE cohort and the overall patient population 
in hospitals. Using this approach, we estimated the actu-
al incidences of BBFEs in our university hospital for the 
last 10 years and evaluated the difference between the 
reported and estimated numbers of BBFEs. 
 
 
MATERIALS AND METHODS 
 
This study was conducted at Osaka University Hospital, 
a 1086-bed tertiary care academic facility in Japan. Da-
ta, including the nature of the injury and occupation, for 
HCWs with BBFE between 2006 and 2015 were ex-
tracted from the electronic database of the Infection 
Control Service and Clinical Laboratory. All BBFEs 
were registered in the Exposure Prevention Information 
Network, Japan. The study protocol was approved by 
the Institutional Review Board of Osaka University 
Hospital (No. 10105-2). The need for informed consent 
was waived because we retrospectively collected data 
without the use of any individually identifying informa-
tion or the application of any intervention. 
In our hospital, we measure seropositivity of the source 
individuals for HBV (antigen/antibody), HCV (anti-
body), HIV (antigen/antibody), human T-cell leukemia 
virus type 1/2 (antibody), and syphilis (rapid plasma re-
agin) using blood samples submitted immediately after 
BBFE events to clearly determine the infectious profile 
at the time of exposure. Of these, we collected data for 
HCV positivity in the source individuals. Also, the an-
nual HCV positivity of the overall patient population at 
our facility was calculated. If HCV antibody was mea-
sured ≥ 2 times within a year for an individual, only one 
of the measurements was included. The HCV antibody 
was measured using the Architect i2000 Analyzer (Ab-
bott Japan Co., Ltd Tokyo, JAPAN). 
Our estimation formula consists as follows; 
i the number of reported BBFEs 
ii the number of reported BBFEs by an unknown 
source 
iii HCV positivity of source individuals in the post-
BBFE cohort, and  
iv HCV positivity in the overall patient population 
Estimated incidence of BBFEs = [(i) - (ii)] x  + (ii) 
We focused on the difference in HCV positivity be-
tween the post-BBFE cohort and overall patient popula-
tion. Theoretically, a BBFE occurs randomly regardless 
of HCV positivity, and the positive rate in the post-
BBFE cohort should be comparable with that in the 
overall patient population. However, the HCV positivity 
of the source individuals in the post-BBFE cohort was 
much higher than that in the overall patient population, 
potentially because of the under-reporting of BBFE 
events. For instance, when a HCW experiences a BBFE 
with an HCV-positive source individual, he or she pre-
sumably reports the exposure to the Infection Control 
Service. However, with an HCV-negative source, the 
incidence may not be reported. With fewer reports of 
BBFEs with HCV-negative sources, the HCV positivity 
in the post-BBFE cohort would be higher. Thus, in the 
estimation formula, we calculated the ratio of HCV pos-
itivity in the post-BBFE cohort to that of the overall pa-
tient population and multiplied it by the number of 
source-apparent BBFEs. 
Statistical analysis was performed using EZR software, 
which is a modified version of R Commander (version 
2.2-5) based on R (version 3.3.1) [17]. We defined the 
annual incidence ratio as the ratio of the estimated 
BBFEs to the reported BBFEs in a year. We applied a 
linear regression line of this ratio to evaluate the differ-
ence in the annual incidence between the reported and 
estimated BBFEs over time. Statistical significance was 
calculated by comparing the regression line to a zero 
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Table 1. Incidences of blood and body fluid exposure (BBFE) at Osaka University Hospital, 2006 to 2015. 
 
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Total 
BBFE incidence 83 102 94 83 101 82 102 105 87 98 937 
Nature of injury 
Needles 69 90 76 66 864 71 80 73 60 69 740 
Sharps 3 6 3 5 3 1 5 11 9 8 54 
Mucocutaneous exposure 3 2 8 4 6 5 14 11 10 13 76 
Unknown 3 2 5 4 1 3 1 1 1 2 23 
Others * 5 2 2 4 5 2 2 9 7 6 44 
Occupation 
Medical doctor 51 42 39 28 47 29 29 38 38 47 388 
Nurse 26 54 48 46 40 44 62 56 41 39 456 
Laboratory technician 2 2 0 3 4 3 5 5 2 5 31 
Service staff 1 3 3 5 7 3 1 4 4 4 35 
Others ** 3 1 4 1 3 3 5 2 2 3 27 
 





Table 2. Annual Hepatitis C virus (HCV) positivity in the post-blood and body fluid exposure (BBFE) cohort and overall pa-
tient population. 
 























































During the study period, a total of 937 BBFEs were re-
ported to the Infection Control Service, including       
740 needle injuries (79.3%), 54 sharp injuries (5.7%), 
76 mucocutaneous exposures (80%), 23 unknown 
events (2.6%), and 44 others (4.7%). By occupation, 
medical doctors (388, 41.7%), nurses (456, 48.6%), lab-
oratory technicians (31, 3.3%), service staff (35, 3.8%), 
and others (27, 2.9%) were affected (Table 1). HCV an-
tibody was examined in 917 of the 937 BBFE events 
(97.9%). The annual HCV positivity between the post-
BBFE cohort (10.2 - 35.1%) and overall patient popula-
tion (4.4 - 6.0%) greatly differed (Table 2). 
Figure 1 shows the numbers of reported and estimated 
BBFEs in each year using the estimation formula, as 
well as their ratios over time. The linear regression 
model revealed that the reported number of BBFEs did 
not change significantly during the study period (the 
slope, 1.315 [95% confidence interval (C.I.): -0.849 to 
3.480, p = 0.199]). However, the annual incidence ratio 
declined significantly (the slope, -0.287 [95% C.I.:          





In this study, we proposed a novel estimation formula to 
determine the actual number of BBFEs by focusing on 
the difference in HCV positivity between the source in-
dividuals in a post-BBFE cohort and the overall patient 
population. HCV is an RNA mono-stranded enveloped 
virus that has a wide distribution, infecting 2 - 3% of 
the world population [18]. For instance, in Japan, the 
HCV prevalence in the general population is reportedly 
1.0 - 1.9% [19]. In the United States, 2.7 million per-
N. Yoshioka et al. 







Figure 1. Annual reported and estimated blood and body fluid exposure (BBFE) incidents and the annual incidence ratio. 
 
A solid line indicates the ratio of estimated BBFEs to reported BBFEs (annual incidence ratios). Bold and fine dotted lines are linear regression 
lines of the annual incidence ratio and reported number of BBFEs, respectively. The annual incidence ratio decreased significantly over time 





sons, accounting for approximately 0.9% of the total 
population, have chronic HCV infection [20]. Thus, our 
equation provides a widely available method for infec-
tion control practitioners to practically estimate the ac-
tual incidence of BBFEs in their facilities. 
Implementation of effective infection control strategies 
can reduce the transmission risk of viral hepatitis and 
HIV [21], and many preventable measures for BBFEs 
have been developed. However, BBFEs might not be re-
ported properly; among the various occupations in hos-
pitals, for instance, medical doctors are less likely to re-
port BBFEs to the responsible sections than other 
HCWs [22]. Thus, poor reporting systems may provide 
incorrect estimates. The result of statistical analysis 
showed that the reported number of BBFEs remained at 
a constant level, while the estimated incidence tended to 
decline over time at our facility. These results can sup-
port the effectiveness of preventive measures for 
BBFEs in our hospital and the ability of our simple ap-
proach to offer an objective evaluation of the actual in-
cidence of BBFEs. 
The strength of this study is the accurate data for HCV 
positivity in the source individuals. Because of addi-
tional costs, previous data for infectious profiles have 
been applied for post-BBFE evaluation in many hospi-
tals, although past data do not necessarily reflect the 
current status. For more than 10 years, we have required 
the known source individuals to submit their blood sam-
ples following BBFE events to understand their infec-
tious profiles. Therefore, the HCV positivity of the 
present post-BBFE cohort is reliable. 
HBV cannot replace HCV in the estimation formula. 
Although the HBV vaccination policy may differ in 
each medical facility or country, the proportion of 
HCWs vaccinated for HBV is higher than that in the 
general population. Thus, measurement of HB antibody 
is not useful for the estimation. Data for other HBV-re-
lated antigens or antibodies are usually not as frequently 
measured in the overall patient population and cannot 
provide a reliable adjustment. In contrast to HBV, vac-
cination for HCV has not been established [23], and this 
disadvantage turned out to be a strength for our method. 
The prevalence of HIV is still lower in Japan than in 
other countries, and its positivity is not applicable for 
the estimation. However, it may be possible to apply 
HIV positivity to our estimation formula in particular 
regions where HIV prevalence is comparatively high. 
Compared to the general population [19], HCV positivi-
ty at our facility was relatively higher, ranging from 
4.4% to 6.0%. Hospitalized and ambulatory patients are 
usually older than the general population. Also, patients 
with HCV infection have been referred to our hospital 
because of its provision of tertiary care. 
Several limitations of this study should be mentioned. 
First, the absence of a gold standard reference for the 
actual BBFE incidence should be noted. However, no 
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matter how much time passes, it is impossible to deter-
mine the actual number because of under-reporting. 
Second, the implementation rates of HCV serology 
among the overall patient population may influence the 
accuracy of the estimation. Less measured in the overall 
population, the HCV positivity, which is a denominator 
in the estimation formula, can vary. In Japan, HCV anti-
body is generally tested when patients are hospitalized 
or undergo surgeries. Therefore, we consider the HCV 
positivity of overall patient population in this study is 
comparatively reliable. Third, the nature of a single fa-
cility study might affect the generalizability of our 
methodology. Also, comparison of the estimated num-
ber of BBFEs among medical facilities may be difficult 





We proposed a new, simple estimation formula for the 
estimation of the actual incidence of BBFEs using the 
difference in HCV positivity between the post-BBFE 
cohort and overall patient population. The reported 
number does not necessarily reflect the true incidence of 
BBFEs in each medical facility, while our method can 
provide a reliable estimation. By following the trend in 
the estimated number, it is possible to better compre-
hend and evaluate the real occurrence of BBFEs at each 
facility. In our facility, although the reported incidence 
of BBFEs did not change, the estimated incidence sig-
nificantly decreased during the study period. Under-re-
porting of BBFEs continues to persist. A better under-
standing of BBFE occurrence in each medical facility 
can lead to appropriate evaluations and countermeasures 
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